NCT03434275View on ClinicalTrials.gov

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

May 21, 2019

Study Completion Date

May 21, 2019

Conditions
Pain, Postoperative
Interventions
DRUG

N1539

Once Daily

DRUG

Placebo

Once Daily

Trial Locations (6)

32960

Research Center, Vero Beach

33321

Research Center, Tamarac

35630

Research Center, Florence

35660

Research Center, Sheffield

36608

Research Center, Mobile

85284

Research Center, Tempe

Sponsors

Lead Sponsor

Baudax Bio
All Listed Sponsors
lead

Baudax Bio

INDUSTRY